dBET-6

N/A

Report date: 2021/12/08 14:03:05
NME

Base Information

Drug NamedBET-6
Drug Alias NamedBET-6
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionBromodomain-containing protein 4 inhibitorsProteolysis
TargetsBromodomain-containing protein 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDana-Farber Cancer InstituteHarvard Medical School
China Registration ClassN/A

Develop Information

Active CompaniesDana-Farber Cancer InstituteHarvard Medical School
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A